Preliminary Study Shows Creatine and Minocycline May Warrant Further Study
In Parkinson�s Disease
A National Institutes of Health-sponsored clinical trial with 200
Parkinson's disease patients has shown that creatine and minocycline may
warrant further consideration for study in a large trial, according to Karl
Kieburtz, M.D., M.P.H., University of Rochester, who spoke today at the
World Parkinson Congress on behalf of the trial investigators.
link medline
Nootrópicos (smartdrugs, drogas inteligentes, potenciadores cognitivos) son sustancias artificiales (medicamentos como piracetam, hydergina, citicolina, fosfatidilserina, vinpocetina, etc.) o naturales (suplementos nutricionales, vitaminas, aminoácidos, hormonas, hierbas, etc. como vitaminas B, piroglutamato, Gingko Biloba, fenilalanina, DHEA, pregnenolona, etc.) que se utilizan para mejorar la capacidad cognitiva (memoria, atención, etc.) en personas con trastornos o normales.
